Pharmaceuticals

Global Sartans Market Set To Expand To $2.72 Billion By 2030 At 9.4% CAGR

May 4, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Large Will The Sartans Market Be By 2030 Compared To Its 2026 Market Size?

The market for sartans has demonstrated consistent expansion in recent years. This market is projected to increase from $22.18 billion in 2025 to $23.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.1%. The expansion observed in prior periods can be attributed to the significant global prevalence of hypertension, the burden of cardiovascular disease, the growing adoption of generic drugs, common hospital-based prescribing practices, and the established long-term safety profile of sartans.

The sartans market size is projected to experience consistent growth in the coming years. It is expected to reach $27.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 4.1%. This expansion during the forecast period is propelled by an aging population, the rising incidence of kidney disease, the demand for cost-effective therapies, the broadening of outpatient treatment, and the proliferation of digital pharmacies. Noteworthy trends for the forecast period include their increasing utilization in hypertension management, the growth of generic angiotensin receptor blockers, a preference for combination cardiovascular therapy, the expansion of online pharmacy distribution, and a focus on renal and cardiovascular protection.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24393&type=smp

Which Key Factors Are Driving The Sartans Market Growth?

The increasing occurrence of hypertension is anticipated to boost the expansion of the sartans market in the future. Hypertension is defined as a state characterized by consistently elevated blood pressure, which can heighten the risk of cardiac issues, strokes, and other serious medical complications. The escalating frequency of hypertension is associated with diets high in salt and processed foods, leading to fluid retention and greater strain on the heart. Sartans address hypertension by inhibiting angiotensin II, a hormone responsible for constricting blood vessels. This action aids in relaxing and broadening the vessels, thereby reducing blood pressure and alleviating the heart’s effort. For instance, in September 2025, as per the World Health Organization, a Switzerland-based international public health agency, approximately 1.4 billion adults aged 30–79 years globally were suffering from hypertension in 2024, accounting for about 33% of the worldwide population. Consequently, the rising prevalence of hypertension is fueling the growth of the sartans market.

How Are Segments Identified Within The Sartans Market Segment Framework?

The sartans market covered in this report is segmented –

1) By Product Type: Valsartan, Telmisartan, Losartan, Irbesartan, Azilsartan, Olmesartan

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Other Distribution Channels

3) By Application: Hypertension, Cardiovascular Diseases, Kidney Diseases, Other Applications

4) By End-User: Hospitals, Other End-Users

Subsegments:

1) By Valsartan: Film-Coated Tablets, Oral Powder Sachets, Triple-Combination Tablets, Ready-To-Use Liquid Formulations

2) By Telmisartan: Soft Gel Capsules, Mouth-Dissolving Strips, Sustained-Release Tablets, Sachet-Packed Granules

3) By Losartan: Chewable Tablets, Pediatric Oral Drops, Effervescent Tablets, Dispersible Tablets

4) By Irbesartan: High-Potency Tablets, Scored Tablets, Hospital Bulk Packs, Blister Strip Packs

5) By Azilsartan: Nanoparticle-Based Tablets, Rapid-Onset Tablets, Unit-Dose Capsules, Microgranule Sachets

6) By Olmesartan: Oral Jelly Formulations, Oral Thin Films, Powder-For-Suspension Packs, Dual-Layer Tablets

What Trends Are Transforming The Sartans Market?

Leading firms within the sartans market are concentrating on creating sophisticated products, including sartans in tablet form, with the aim of improving the effectiveness of treatment and patient compliance. These tablet-form sartans constitute oral drugs containing sartan compounds, which function by obstructing the impact of angiotensin II, thereby facilitating blood vessel relaxation and lowering blood pressure. An example of this is in July 2024, when Zydus Lifesciences, a pharmaceutical entity based in India, secured approval from the US Food and Drug Administration (FDA) for its Valsartan Tablets USP (40 mg, 80 mg). The branding for these particular tablets is Diovan. Such tablets are prescribed for addressing hypertension and heart failure, enhancing survival following a heart attack in adults, and are also appropriate for pediatric patients from one year and older.

Who Are The Companies Competing Within The Sartans Market?

Major companies operating in the sartans market are Viatris Inc., Teva Pharmaceutical Industries Ltd., Intas Pharmaceuticals Ltd., Sun Pharmaceutical Industries Ltd., Apotex Inc., Aurobindo Pharma Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Ltd., Cadila Pharmaceuticals Ltd., Lupin Ltd., Zydus Lifesciences Ltd., Torrent Pharmaceuticals Ltd., Alembic Pharmaceuticals Ltd., Unichem Laboratories Ltd., Emcure Pharmaceuticals Ltd., Mylan N.V., Hikma Pharmaceuticals PLC, Glenmark Pharmaceuticals Ltd., Abbott Laboratories, Novartis AG, Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Bayer AG, Merck & Co. Inc.

Get The Full Sartans Market Report:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

Which Region Has The Greatest Market Share In The Sartans Market?

North America was the largest region in the sartans market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sartans market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Sartans Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/sartans-global-market-report

Browse Through More Reports Similar to the Global Sartans Market 2026, By The Business Research Company

Canned Sardines Market Report 2026

https://www.thebusinessresearchcompany.com/report/canned-sardines-global-market-report

Sarcoma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/sarcoma-drugs-global-market-report

Pineapples Market Report 2026

https://www.thebusinessresearchcompany.com/report/pineapples-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795